SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0000950170-23-044389
Filing Date
2023-08-24
Accepted
2023-08-24 16:27:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2793
  Complete submission text file 0000950170-23-044389.txt   4229
Mailing Address C/O MEDIVATION, INC. 525 MARKET ST., 36TH FLOOR SAN FRANCISCO CA 94105
Business Address
Svoronos Dawn (Reporting) CIK: 0001574579 (see all company filings)

Type: 144

Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Subject) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-36687 | Film No.: 231202520
SIC: 2834 Pharmaceutical Preparations